Donald Trump’s pick of Senator Jeff Sessions for attorney General could help solidify Bayer AG’s $66 billion purchase of Monsanto, which is currently undergoing state and federal antitrust investigations.
Source: EcoWatch
Monsanto announced last week that it licensed the CRISPR-Cas9 gene-editing tool from the Broad Institute in Boston for use in seed development. The technology will allow the agritech giant to edit crops’ DNA by “snipping” away undesirable traits – or adding in more desirable ones – of the plants’ genetic codes. Frankenfood? [1]
Source: Business Insider
